Related Experiment Video
Updated: May 22, 2026
Culturing Microglia from the Neonatal and Adult Central Nervous System
Published on: August 9, 2013
Activated microglial cells synthesize and secrete AGE-albumin
Kyunghee Byun1, Enkhjaigal Bayarsaikhan, Daesik Kim
1Center for Genomics and Proteomics, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.
Abstract:
A holy grail of curing neurodegenerative diseases is to identify the main causes and mechanisms underlying neuronal death. Many studies have sought to identify these targets in a wide variety of ways, but a more important task is to identify critical molecular targets and their origins. Potential molecular targets include advanced glycation end products (AGEs) that can promote neuronal cell death, thereby contributing to neurodegenerative disorders such as Alzheimer disease or Parkinson disease. In this study, we showed that AGE-albumin (glycated albumin) is synthesized in microglial cells and secreted in the human brain. Our results provide new insight into which microglial cells can promote the receptor for AGE-mediated neuronal cell death, eventually leading to neurodegenerative diseases.
Insights
Advanced glycation end products (AGEs), specifically AGE-albumin, are synthesized and secreted by microglial cells in the human brain. This finding offers new insights into the mechanisms of neuronal cell death in neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Neurodegenerative diseases like Alzheimer's and Parkinson's are characterized by neuronal death.
- Identifying critical molecular targets and their origins is crucial for understanding these diseases.
- Advanced glycation end products (AGEs) are implicated in promoting neuronal cell death.
Purpose of the Study:
- To investigate the origin and role of AGE-albumin in the human brain.
- To elucidate the involvement of microglial cells in AGE-mediated neuronal cell death.
- To identify critical molecular targets contributing to neurodegenerative disorders.
Main Methods:
- Immunohistochemistry to detect AGE-albumin in human brain tissue.
- Cell culture experiments using microglial cells.
- Analysis of AGE-receptor interactions and downstream signaling pathways.
Main Results:
- AGE-albumin was found to be synthesized and secreted by microglial cells in the human brain.
- Microglial-derived AGE-albumin promotes neuronal cell death via AGE-receptor pathways.
- This process contributes to the pathogenesis of neurodegenerative diseases.
Conclusions:
- Microglial cells are a source of AGE-albumin in the brain.
- AGE-albumin plays a significant role in AGE-receptor-mediated neuronal death.
- Targeting microglial AGE production may offer a therapeutic strategy for neurodegenerative diseases.
